Elevance Health EPS - Earnings per Share 2012-2025 | ELV
Elevance Health annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Elevance Health EPS for the quarter ending September 30, 2025 was $5.32, a 22.02% increase year-over-year.
- Elevance Health EPS for the twelve months ending September 30, 2025 was $24.53, a 10.74% decline year-over-year.
- Elevance Health 2024 annual EPS was $25.68, a 1.82% increase from 2023.
- Elevance Health 2023 annual EPS was $25.22, a 3.87% increase from 2022.
- Elevance Health 2022 annual EPS was $24.28, a 2.69% decline from 2021.
| Elevance Health Annual EPS | |
|---|---|
| 2024 | $25.68 |
| 2023 | $25.22 |
| 2022 | $24.28 |
| 2021 | $24.95 |
| 2020 | $17.98 |
| 2019 | $18.47 |
| 2018 | $14.19 |
| 2017 | $14.35 |
| 2016 | $9.21 |
| 2015 | $9.38 |
| 2014 | $8.99 |
| 2013 | $8.20 |
| 2012 | $8.18 |
| 2011 | $7.25 |
| Elevance Health Quarterly EPS | |
|---|---|
| 2025-09-30 | $5.32 |
| 2025-06-30 | $7.72 |
| 2025-03-31 | $9.61 |
| 2024-12-31 | $1.88 |
| 2024-09-30 | $4.36 |
| 2024-06-30 | $9.85 |
| 2024-03-31 | $9.59 |
| 2023-12-31 | $3.68 |
| 2023-09-30 | $5.45 |
| 2023-06-30 | $7.79 |
| 2023-03-31 | $8.30 |
| 2022-12-31 | $3.61 |
| 2022-09-30 | $6.62 |
| 2022-06-30 | $6.73 |
| 2022-03-31 | $7.32 |
| 2021-12-31 | $4.86 |
| 2021-09-30 | $6.13 |
| 2021-06-30 | $7.25 |
| 2021-03-31 | $6.71 |
| 2020-12-31 | $2.26 |
| 2020-09-30 | $0.87 |
| 2020-06-30 | $8.91 |
| 2020-03-31 | $5.94 |
| 2019-12-31 | $3.65 |
| 2019-09-30 | $4.55 |
| 2019-06-30 | $4.36 |
| 2019-03-31 | $5.91 |
| 2018-12-31 | $1.60 |
| 2018-09-30 | $3.62 |
| 2018-06-30 | $3.98 |
| 2018-03-31 | $4.99 |
| 2017-12-31 | $4.66 |
| 2017-09-30 | $2.80 |
| 2017-06-30 | $3.16 |
| 2017-03-31 | $3.73 |
| 2016-12-31 | $1.37 |
| 2016-09-30 | $2.30 |
| 2016-06-30 | $2.91 |
| 2016-03-31 | $2.63 |
| 2015-12-31 | $0.73 |
| 2015-09-30 | $2.43 |
| 2015-06-30 | $3.13 |
| 2015-03-31 | $3.09 |
| 2014-12-31 | $1.81 |
| 2014-09-30 | $2.22 |
| 2014-06-30 | $2.56 |
| 2014-03-31 | $2.40 |
| 2013-12-31 | $0.51 |
| 2013-09-30 | $2.16 |
| 2013-06-30 | $2.64 |
| 2013-03-31 | $2.89 |
| 2012-12-31 | $1.56 |
| 2012-09-30 | $2.15 |
| 2012-06-30 | $1.94 |
| 2012-03-31 | $2.53 |
| 2011-12-31 | $1.02 |
| 2011-09-30 | $1.90 |
| 2011-06-30 | $1.89 |
| 2011-03-31 | $2.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $82.379B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.388B | 30.55 |
| HCA Healthcare (HCA) | United States | $109.378B | 18.11 |
| CVS Health (CVS) | United States | $102.418B | 11.78 |
| Cencora (COR) | United States | $67.098B | 21.63 |
| Natera (NTRA) | United States | $32.905B | 0.00 |
| DiDi Global (DIDIY) | China | $23.862B | 22.04 |
| Labcorp Holdings (LH) | United States | $21.055B | 16.05 |
| Medpace Holdings (MEDP) | United States | $17.138B | 42.55 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.432B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Viatris (VTRS) | United States | $15.399B | 5.74 |
| ICON (ICLR) | Ireland | $14.802B | 14.69 |
| Solventum (SOLV) | United States | $13.881B | 13.47 |
| Revvity (RVTY) | United States | $12.487B | 22.99 |
| CochLear (CHEOY) | Australia | $11.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.778B | 20.76 |
| Avantor (AVTR) | United States | $8.591B | 13.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.606B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.449B | 0.00 |
| HealthEquity (HQY) | United States | $7.201B | 26.93 |
| BrightSpring Health Services (BTSG) | United States | $6.965B | 41.53 |
| PACS (PACS) | United States | $6.598B | 40.12 |
| Bausch + Lomb (BLCO) | Canada | $6.181B | 40.58 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.186B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.175B | 55.76 |
| Concentras Parent (CON) | United States | $2.599B | 16.22 |
| Organon (OGN) | United States | $2.192B | 2.31 |
| Progyny (PGNY) | United States | $2.176B | 42.78 |
| Surgery Partners (SGRY) | United States | $2.080B | 26.80 |
| Pediatrix Medical (MD) | United States | $1.904B | 11.37 |
| Establishment Labs Holdings (ESTA) | United States | $1.893B | 0.00 |
| Ardent Health (ARDT) | United States | $1.266B | 4.13 |
| Teladoc Health (TDOC) | United States | $1.241B | 0.00 |
| Nutex Health (NUTX) | United States | $1.221B | 9.33 |
| CareDx (CDNA) | United States | $1.038B | 16.97 |
| GoodRx Holdings (GDRX) | United States | $0.971B | 15.89 |
| Omada Health (OMDA) | United States | $0.934B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.750B | 4.26 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.708B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Enhabit (EHAB) | United States | $0.554B | 24.89 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.466B | 0.00 |
| SBC Medicals (SBC) | United States | $0.457B | 8.42 |
| Agilon Health (AGL) | United States | $0.394B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.349B | 5.62 |
| Oncology Institute (TOI) | United States | $0.347B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.280B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.085B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |